Resonant Capital Advisors, LLC

Source: SEC Form 13F · as of Mar 2026

Resonant Capital Advisors, LLC holds 29 biotech & pharma companies tracked by BioSniper, totaling $53.5M in value as of Mar 2026 (SEC Form 13F).

Companies held

29

Total value held

$53.5M

CompanySharesValue
MCKMcKesson Corporation8,902$7.7M
LLYELI LILLY & Co6,123$5.6M
AMGNAMGEN INC15,261$5.4M
JNJJOHNSON & JOHNSON19,429$4.7M
GILDGILEAD SCIENCES, INC.30,046$4.2M
MRKMerck & Co., Inc.31,176$3.8M
ABBVAbbVie Inc.16,835$3.7M
BMYBRISTOL MYERS SQUIBB CO51,916$3.1M
UNHUnitedHealth Group Incorporated Common Stock (DE)9,392$2.5M
PFEPFIZER INC61,057$1.7M
CAHCardinal Health Inc.7,684$1.6M
ABTABBOTT LABORATORIES13,860$1.4M
PMPhilip Morris International Inc7,851$1.3M
NVSNovartis AG6,164$942K
VRTXVERTEX PHARMACEUTICALS INC / MA1,776$793K
ELANElanco Animal Health Inc31,892$763K
AZNASTRAZENECA PLC3,572$704K
GMOptec International, Inc.5,710$425K
REGNREGENERON PHARMACEUTICALS, INC.501$387K
NVONovo Nordisk A/S9,371$356K
BIIBBIOGEN INC.1,874$344K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)6,131$340K
CORCencora Inc.951$299K
ELVElevance Health Inc.949$278K
IDXXIDEXX LABORATORIES INC /DE436$245K
GEHCGE HealthCare Technologies Inc.3,283$234K
ZTSZoetis Inc.1,824$216K
SNYSanofi4,289$207K
RDYDR REDDYS LABORATORIES LTD10,526$146K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Resonant Capital Advisors, LLC — Biotech 13F Holdings & Portfolio | BioSniper